Global Veterinary Molecular Diagnostics Market to Reach $984.2 Million by 2030
The global market for Veterinary Molecular Diagnostics estimated at US$553.2 Million in the year 2022, is projected to reach a revised size of US$984.2 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2022-2030. Instruments & Software, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$342.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits & Reagents segment is readjusted to a revised 8.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $147.2 Million, While China is Forecast to Grow at 11.1% CAGR
The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$147.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$238.9 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.Select Competitors (Total 42 Featured) -
- BIOMEDICA Medizinprodukte GmbH & Co., KG
- Bioneer Corporation
- HealthGene Corporation
- Idexx Laboratories, Inc.
- Novacyt Group
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Vca, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BIOMEDICA Medizinprodukte GmbH & Co., KG
- Bioneer Corporation
- HealthGene Corporation
- Idexx Laboratories, Inc.
- Novacyt Group
- Qiagen NV
- Thermo Fisher Scientific, Inc.
- Vca, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 173 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 553.2 Million |
Forecasted Market Value ( USD | $ 984.2 Million |
Compound Annual Growth Rate | 7.5% |
Regions Covered | Global |